KITS Eyecare Ltd. has announced an upward revision to its Q3 2024 revenue guidance, exceeding the previously projected range of $39 million to $41 million. This revision follows a record-breaking week of sales, reaching approximately $3.5 million for the week ending August 31, 2024. The company attributes this strong performance to increased demand and improved operational efficiency.
Results for: Eyecare
KITS Expands Product Line with New Daily Color Contact Lenses, Capitalizing on Growing Market Demand
KITS Eyecare Ltd. has launched KITS Daily Color Contacts, adding a vibrant new dimension to its existing range of contact lenses. This expansion comes at a time when the global colored contact lens market is experiencing significant growth, with an estimated value of USD $9.82 Billion by 2033. KITS aims to capitalize on this trend with its innovative and high-quality color contact lenses, available in a range of colors to enhance and define the look of the eyes.
Avulux and Eyenavision have teamed up to introduce Chemistrie Avulux, a new on-demand eyeglass clip designed for individuals with migraine and light sensitivity. This innovative product combines Avulux’s clinically proven migraine lenses with Eyenavision’s Chemistrie lens layering system, offering a convenient solution for patients seeking relief from migraine triggers.